Mycobacteria‐induced granuloma necrosis depends on IRF‐1
暂无分享,去创建一个
Roland Lang | T. Decker | N. Reiling | S. Ehlers | J. Mages | U. Kalinke | R. Lang | Thomas Decker | S. Aly | Jörg Mages | Ulrich Kalinke | Stefan Ehlers | Norbert Reiling | Sahar Aly
[1] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[2] A. Izzo,et al. A matrix metalloproteinase inhibitor promotes granuloma formation during the early phase of Mycobacterium tuberculosis pulmonary infection. , 2004, Tuberculosis.
[3] H. Arai,et al. Structure and function of phosphatidylserine-specific phospholipase A1. , 2002, Biochimica et biophysica acta.
[4] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[5] G Murphy,et al. A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.
[6] T. Welte,et al. Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation , 2004, European Respiratory Journal.
[7] S. Alonso,et al. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy , 2007, Proceedings of the National Academy of Sciences.
[8] G. Bancroft,et al. Production of Matrix Metalloproteinases in Response to Mycobacterial Infection , 2001, Infection and Immunity.
[9] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[10] H. Yamada,et al. STAT1 knockout mice are highly susceptible to pulmonary mycobacterial infection. , 2004, The Tohoku journal of experimental medicine.
[11] S. Ehlers,et al. Oxygen status of lung granulomas in Mycobacterium tuberculosis‐infected mice , 2006, The Journal of pathology.
[12] Angelo A. Izzo,et al. Role for Matrix Metalloproteinase 9 in Granuloma Formation during Pulmonary Mycobacterium tuberculosis Infection , 2006, Infection and Immunity.
[13] J. Mudgett,et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] Hiroyuki Yamada,et al. Interferon Regulatory Factor 1 in Mycobacterial Infection , 2002, Microbiology and immunology.
[15] M. Tani,et al. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. , 2007, Cellular signalling.
[16] A. Balows,et al. Topley & Wilson`s microbiology and microbial infections , 1998 .
[17] I. Orme,et al. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[18] T. Laskay,et al. Interferon‐gamma‐dependent mechanisms of mycobacteria‐induced pulmonary immunopathology: the role of angiostasis and CXCR3‐targeted chemokines for granuloma necrosis , 2007, The Journal of pathology.
[19] William C. Parks,et al. Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.
[20] T. Welte,et al. Cathepsin K – a marker of macrophage differentiation? , 2001, The Journal of pathology.
[21] R. North,et al. Immunity to tuberculosis. , 2003, Annual review of immunology.
[22] T. Mak,et al. The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis 1 , 2005, The Journal of Immunology.
[23] K. Honda,et al. The contribution of transcription factor IRF1 to the interferon-γ–interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells , 2008, Nature Immunology.
[24] John Quackenbush,et al. Genesis: cluster analysis of microarray data , 2002, Bioinform..
[25] P. Chomczyński,et al. Substitution of chloroform by bromo-chloropropane in the single-step method of RNA isolation. , 1995, Analytical biochemistry.
[26] G. Fields,et al. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). , 1994, The Journal of biological chemistry.
[27] R. Appelberg,et al. Immunological basis of the development of necrotic lesions following Mycobacterium avium infection , 2002, Immunology.
[28] S. Ehlers,et al. DTH‐Associated Pathology , 2010 .
[29] Alimuddin Zumla,et al. Lung remodeling in pulmonary tuberculosis. , 2005, The Journal of infectious diseases.
[30] F. Schmitz,et al. Interferon‐regulatory‐factor 1 controls Toll‐like receptor 9‐mediated IFN‐β production in myeloid dendritic cells , 2007 .
[31] S. Ehlers,et al. Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55‐gene‐deficient mice aerogenically infected with highly virulent Mycobacterium avium , 1999, The Journal of pathology.
[32] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[33] S. Ehlers,et al. αβ T Cell Receptor-positive Cells and Interferon-γ, but not Inducible Nitric Oxide Synthase, Are Critical for Granuloma Necrosis in a Mouse Model of Mycobacteria-induced Pulmonary Immunopathology , 2001, The Journal of experimental medicine.
[34] J. Estep,et al. Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli , 1996, Infection and immunity.
[35] T. Welte,et al. Pivotal role of cathepsin K in lung fibrosis. , 2004, The American journal of pathology.
[36] J. Casanova,et al. Requirement for both IL‐12 and IFN‐γ signaling pathways in optimal IFN‐γ production by human T cells , 2002 .
[37] I. Orme,et al. Lymphadenitis as a major element of disease in the guinea pig model of tuberculosis. , 2006, Tuberculosis.